U.S. COVID-19 Update eNewsletter
March 10, 2023

Correlation Between COVID-19 Infection, New-Onset Diabetes Risk
Findings from a recent cohort study published in the Journal of the American Medical Association indicated that the possibility of developing new-onset diabetes may be augmented by post-COVID-19 infection. Moreover, the risk of new-onset type 2 diabetes appears to be smaller in individuals already vaccinated against COVID-19 by the time they were infected. Learn more about the results of this study.


Poor Oxygenation Identified in Severe COVID-19 Infections
The results from a multicenter cross-sectional study published in the American Journal of Respiratory and Critical Care Medicine demonstrated that patients with severe COVID-19 infection have immunoglobulin A autoantibodies targeting pulmonary surfactant proteins B and C. Moreover, these autoantibodies in the lung surfactant may prevent lung surfactant function, possibly impacting alveolar collapse and poor oxygenation, causing more severe infection. Read more.

Estimating Incidence of Long-Term Fatigue Post-COVID-19 Infection
In a recent publication in the journal Clinical Infectious Diseases, researchers sought to examine the incidence of prolonged symptoms 3 months post-SARS-CoV-2 infection across three variant time periods, including pre-Delta, Delta, and Omicron periods. According to findings, an estimated one in eight individuals experience severe fatigue that persists for 3 or more months post-COVID-19 infection. Read more.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App